Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder
Not Applicable
Completed
- Conditions
- Functional Bowel Disorders
- Interventions
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2017-09-15
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 25
- Registration Number
- NCT00617396
- Locations
- 🇺🇸
UNC Center for Functional GI & Motility Disorders, Chapel Hill, North Carolina, United States
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
Not Applicable
Completed
- Conditions
- Diarrhea Predominant Irritable Bowel Syndrome
- Interventions
- Other: Very low carbohydrate diet
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2017-10-16
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 17
- Registration Number
- NCT00616200
- Locations
- 🇺🇸
UNC Center for Functional GI & Motility Disorders, Chapel Hill, North Carolina, United States
Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
Phase 2
Terminated
- Conditions
- Weight Gain
- Interventions
- Drug: metforminBehavioral: healthy lifestyle intervention
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2012-12-31
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 1
- Registration Number
- NCT00617058
- Locations
- 🇺🇸
University of North Carolina, Department of Psychiatry, Chapel HIll, North Carolina, United States
Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2014-03-11
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 9
- Registration Number
- NCT00617240
- Locations
- 🇺🇸
University of North Carolina, Department of Psychiatry, Chapel Hill, North Carolina, United States
Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies
Not Applicable
Completed
- Conditions
- Allergic Rhinitis
- Interventions
- Other: live attenuated influenza virus (LAIV) with clean airOther: LAIV and diesel exhaust particles
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 54
- Registration Number
- NCT00617110
- Locations
- 🇺🇸
US EPA Human Studies Facility, Chapel Hill, North Carolina, United States
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
Phase 2
Terminated
- Conditions
- HIV Infections
- Interventions
- Drug: Raltegravir; valproic acid
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2011-10-25
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 6
- Registration Number
- NCT00614458
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
Phase 1
Completed
- Conditions
- Alcohol Dependence
- Interventions
- Drug: Naltrexone, Baclofen, Placebo and Behavior Therapy
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2011-05-06
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 40
- Registration Number
- NCT00614328
Brain Imaging of Psychotherapy for Depression
Not Applicable
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Behavioral: Brief Behavioral Activation Treatment for Depression
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 27
- Registration Number
- NCT00609453
- Locations
- 🇺🇸
Duke-UNC Brain Imaging and Analysis Center, Durham, North Carolina, United States
Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 12
- Registration Number
- NCT00609531
- Locations
- 🇺🇸
UNC-Chapel Hill, Chapel Hill, North Carolina, United States
GIOP Prevention Among People With Rheumatoid Arthritis
Not Applicable
Completed
- Conditions
- OsteoporosisRheumatoid Arthritis
- Interventions
- Behavioral: Tailored Materials Plus Physician FeedbackBehavioral: Tailored MaterialsBehavioral: Generic MaterialsBehavioral: No Information
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2015-06-16
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 273
- Registration Number
- NCT00609830
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill School of Pharmacy, Chapel Hill, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath